Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 331-335    DOI: 10.31083/j.ceog.2021.02.2317
Original Research Previous articles | Next articles
Fresh versus frozen blastocyst transfer outcomes deriven from the same ICSI cycle in male factor infertility
Seda Karabulut1, *(), Pelin Kutlu2, Oya Korkmaz1, M. Volkan Bülbül1, İlknur Keskin1
1Department of Hsitology and Embryology, School of Medicine, Istanbul Medipol University, Beykoz, 34820 Istanbul, Turkey
2IVF center, Medicana Çamlıca Hospital, Çamlıca, 34692 Istanbul, Turkey
Download:  PDF(170KB)  ( 98 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The aim of this study was to investigate the clinical outcomes of fresh and frozen-thawed blastocyst transfer deriven from the same ICSI cycle because of male infertility. 2372 couples undergoing a total of 5075 ICSI cycles (2372 fresh + 2703 frozen embryo transfer) were enrolled in the study. Female factor infertility cases were excluded to prevent from the contribution of maternal factors that would influence the outcomes dramatically. Only the cycles for which day 5 blastocyst transfer was performed, had at least 1 surplus blastocyst available for freezing, and had at least one frozen embryo transfer (FET) cycle were included in the study. Clinical pregnancy rates and live birth rates were compared between fresh and FET cycles. No statistically significant difference was obtained in clinical pregnancy rates and live birth rates of fresh versus FET cycles of day 5 transfers, regardless of the number of embryos transferred. According to the results of the recent study, frozen embryo cycles appear to be as effective as fresh ICSI cycles provided that the patients' embryos can develop into blastocysts, which is proven by using the same patient as the control group regardless of the result of previous ICSI attempt but further research is required to test the efficacy in terms of cost-effectiveness and the duration for conception.
Key words:  Frozen embryo      Blastocyst      ICSI      FET     
Submitted:  07 October 2020      Revised:  10 December 2020      Accepted:  16 December 2020      Published:  15 April 2021     
*Corresponding Author(s):  Seda Karabulut     E-mail:  sedakarabulut@medipol.edu.tr

Cite this article: 

Seda Karabulut, Pelin Kutlu, Oya Korkmaz, M. Volkan Bülbül, İlknur Keskin. Fresh versus frozen blastocyst transfer outcomes deriven from the same ICSI cycle in male factor infertility. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 331-335.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2317     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/331

[1] Arzu Yurci, Aret Kamar, Nurettin Turktekin, Ramazan Ozyurt. Comparison of immediate versus delayed frozen embryo transfer on reproductive outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 263-269.
[2] R. Duraker, E.S. Guvendag Guven, S. Dilbaz, A. Mentese, S. Aydın, S. Guven. Oxidative stress status in severe OHSS patients who underwent long agonist protocol intracytoplasmic sperm injection cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 312-316.
[3] Elisa Zambrotta, Luisa Maria Di Gregorio, Federica Di Guardo, Roberta Agliozzo, Giuliana Chiara Maugeri, Ferdinando Antonio Gulino, Silvia Cutello, Maria Cecilia Cerana, Marco Palumbo. Congenital uterine anomalies and perinatal outcomes: a retrospective single-center cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 160-163.
[4] Iulia Baciu, Dalila-Ana Domuncu, Tiberiu Domuncu, Anca Marina Ciobanu, Theodor Voiosu, Gheorghe Peltecu, Anca Maria Panaitescu. Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 9-18.
[5] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[6] Jing-Jing Jiang, Ting Han, Yan-Hui Zhu. The early second-trimester multifetal pregnancy reduction improves pregnancy outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 164-167.
[7] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[8] C.W. Kim, D.H. Lee, B.S. Joo, K.S. Lee. Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 847-855.
[9] J.R. Huang, X. Li, Q.Z. Peng, J.J. Zhang, X.X. Lin, L.Q. Xie, X.H. Wu, W.S. Zhang. Elective embryo or fetal reduction for caesarean scar pregnancy combined with intrauterine pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 867-874.
[10] Q.C. Wu, L. Sun, Y.S. Xu, X.M. Yang, L.K. Zheng. Diagnosis of fetal nemaline myopathy by whole-exome sequencing: case report and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 915-919.
[11] M. Elmahdy, I. Elfourtia, H. Maghraby. Office hysteroscopy in cases of recurrent implantation failure; Do or not to do[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 723-728.
[12] S. Han, S. Choi, S. Nah, Y.H. Lee. Preterm labor in mild carbon monoxide poisoning: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 805-806.
[13] Sh. Gaafar, T. Hanafy, S. El Morshedy, H. Mansour. Effect of extended embryo culture after thawing on clinical pregnancy rate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 764-768.
[14] K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku. Anti-E alloimmunization in a pregnancy with a low antibody titer[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 614-616.
[15] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[5] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[6] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[7] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[8] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .